These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31606384)

  • 1. Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome.
    Borshchev YY; Uspensky YP; Galagudza MM
    Life Sci; 2019 Nov; 237():116932. PubMed ID: 31606384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Drugs Today (Barc); 2006 Nov; 42(11):741-54. PubMed ID: 17171193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism.
    Arshad N'; Lin TS; Yahaya MF
    CNS Neurol Disord Drug Targets; 2018; 17(8):595-603. PubMed ID: 30047340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
    Shinjyo N; Parkinson J; Bell J; Katsuno T; Bligh A
    J Integr Med; 2020 Mar; 18(2):125-151. PubMed ID: 32005442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.
    Alfaro FJ; Gavrieli A; Saade-Lemus P; Lioutas VA; Upadhyay J; Novak V
    Metabolism; 2018 Jan; 78():52-68. PubMed ID: 28920863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concept of vascular cognitive impairment.
    Erkinjuntti T; Gauthier S
    Front Neurol Neurosci; 2009; 24():79-85. PubMed ID: 19182465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Syndrome: Is It Time to Add the Central Nervous System?
    Rojas M; Chávez-Castillo M; Pirela D; Parra H; Nava M; Chacín M; Angarita L; Añez R; Salazar J; Ortiz R; Durán Agüero S; Gravini-Donado M; Bermúdez V; Díaz-Camargo E
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34208833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension, brain damage and cognitive decline.
    Gąsecki D; Kwarciany M; Nyka W; Narkiewicz K
    Curr Hypertens Rep; 2013 Dec; 15(6):547-58. PubMed ID: 24146223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome.
    Mellendijk L; Wiesmann M; Kiliaan AJ
    Nutrients; 2015 Nov; 7(11):9416-39. PubMed ID: 26580647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?
    Umegaki H
    Age Ageing; 2010 Jan; 39(1):8-10. PubMed ID: 19917634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular basis for brain degeneration: faltering controls and risk factors for dementia.
    Kalaria RN
    Nutr Rev; 2010 Dec; 68 Suppl 2(Suppl 2):S74-87. PubMed ID: 21091952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects and pathogenetic mechanisms of cognitive impairment in arterial hypertension].
    Puddu GM; Zito M; D'Andrea L; Cervone C; Lamanna P; Abate G
    Minerva Cardioangiol; 1996 Jun; 44(6):285-97. PubMed ID: 8927259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcortical ischemic cerebrovascular dementia.
    Menon U; Kelley RE
    Int Rev Neurobiol; 2009; 84():21-33. PubMed ID: 19501711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of vascular cognitive impairment and dementia.
    Erkinjuntti T
    J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can stroke cause neurodegenerative dementia?
    Cumming TB; Brodtmann A
    Int J Stroke; 2011 Oct; 6(5):416-24. PubMed ID: 21951407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, mild cognitive impairment, and dementia.
    Panza F; Frisardi V; Seripa D; Imbimbo BP; Sancarlo D; D'Onofrio G; Addante F; Paris F; Pilotto A; Solfrizzi V
    Curr Alzheimer Res; 2011 Aug; 8(5):492-509. PubMed ID: 21605050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
    Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH
    Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension and dementia].
    Hanon O
    Ann Cardiol Angeiol (Paris); 2014 Jun; 63(3):204-8. PubMed ID: 24970721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.